MARKSANS.NS · Marksans Pharma Limited
India · RS rating 87 · As of 2026-10-14
| Price | 314.15 INR |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 44 / 82 / 94 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 44 / 49 / 61 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +6.1% |
| Sales growth Q/Q | -1.8% |
| Distance from 52-week high | +9.6% |
| Market cap (USD) | $1.5B |